About REGENXBIO Inc.

Website
Website
Employees
Employees
201-500 employees View all
Industry
Industry
biotechnology
Location
Location
Rockville, Maryland (MD), United States
Description
Information
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and third‐party NAV Technology Platform licensees. Revenue: 10.4 MILLION USD

REGENXBIO Inc. Alternatives

Frequently Asked Questions about REGENXBIO Inc.

What is REGENXBIO Inc. email format?

The widely used REGENXBIO Inc. email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.


What is REGENXBIO Inc. customer service number?

To contact REGENXBIO Inc. customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more